JPRN-UMIN000027024已完成未知
The verification study for blood lipid reduction effects : a randomized double-blind, parallel-group, placebo-controlled study - The verification study for blood lipid reduction effects
ORYZA OIL & FAT CHEMICAL CO., LTD.0 个研究点目标入组 20 人开始时间: 2017年9月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, or other chronic diseases 3. Currently taking medicines and/or herbal medicines 4. Those who eat Food with Functional Claims of the LDL-cholesterol reduction effects on a daily basis 5. Those who eat and/or drink Food for Specified Health Uses and/or Food with Function Claims on a daily basis 6. Allergic to medicines or foods related to the test food of this trial 7. Pregnant, lactating, or planning to get pregnant during the trial period 8. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 9. Judged unsuitable for participating in this trial by physician
研究者
相似试验
已完成
不适用
The verification study for blood lipid reduction effects: a randomized, double-blind, controlled trialHealthy adultsJPRN-UMIN000023894ORTHOMEDICO, Inc.14
已完成
不适用
Substudy of lipid lowering trial on prevention of atherosclerosis in 75 or older on cholesterol absorption and synthesisHyper-LDL-cholesterolemiaJPRN-UMIN000002292International University of Health and Welfare1,000
已完成
不适用
A study for evaluating the LDL cholesterol reduction effect by ingestion of tea catechins containing beverageHealthy adultJPRN-UMIN000023185TTC Co.,Ltd.120
已完成
1 期
A study to see if Green tea (Camellia Sinensis 3x) can lower the cholesterol levelCTRI/2019/01/016860Father Muller Research Centre40
招募中
不适用
Study for evaluation of cholesterol lowering effect, dose and safety of Bifidobacterium breve IDCC 4401KCT0003040Ildong pharmaceutical66